Abstract:Introduction of SSRI as the first-line pharmacotherapy options for depression, which purpose is to increase the concentrations of 5-HT in brain and help reduce depressive symptoms. However, there are still many limitations to the effectiveness of these treatment strategies, 30-40% of patients do not respond to treatment at all, and even suicide occurs. In the present study, we revealed that increasing brain 5-HT concentration is not the best treatment options. When we injected sufficient amounts of 5-HT into t… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.